ArticleMarine drugs2024

Exploring Marine-Derived Compounds: In Silico Discovery of Selective Ketohexokinase (KHK) Inhibitors for Metabolic Disease Therapy.

Mansour S AlturkiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.